-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 9, Yiling Pharmaceutical issued an announcement stating that the company had received the Approval Notice for Supplementary Drug Application for Azithromycin tablets approved and issued by the State Food and Drug Administration.
Azithromycin is a semi-synthetic 15-membered macrolide antibiotic, which is a commonly used macrolide antibiotic in clinical practice
Acute onset of chronic bronchitis bacterial infection caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae
Azithromycin tablets are a category A variety of the National Medical Insurance Catalog (2020 edition) and a variety of the National Essential Medicines Catalog (2018 edition)